This article has been cited by
1Neuropathic Corneal Pain
Gabriela Dieckmann,Sunali Goyal,Pedram Hamrah
Ophthalmology.2017;124(11)S34
[DOI]
2Targeting the ß2-integrin LFA-1, reduces adverse neuroimmune actions in neuropathic susceptibility caused by prenatal alcohol exposure
Joshua J. Sanchez,Jacob E. Sanchez,Shahani Noor,Chaselyn D. Ruffaner-Hanson,Suzy Davies,Carston R. Wagner,Lauren L. Jantzie,Nikolaos Mellios,Daniel D. Savage,Erin D. Milligan
Acta Neuropathologica Communications.2019;7(1)S34
[DOI]
3Synthetic Approaches to New Drugs Approved During 2016
Andrew C. Flick,Hong X. Ding,Carolyn A. Leverett,Sarah J. Fink,Christopher J. O’Donnell
Journal of Medicinal Chemistry.2018;61(16)7004
[DOI]
4Therapeutic inhibitors for the treatment of dry eye syndrome
Candela Rodríguez-Pomar,Jesus Pintor,Basilio Colligris,Gonzalo Carracedo
Expert Opinion on Pharmacotherapy.2017;18(17)1855
[DOI]
5Targets of immunomodulation in bacterial endophthalmitis
Frederick C. Miller,Phillip S. Coburn,Mursalin Md Huzzatul,Austin L. LaGrow,Erin Livingston,Michelle C. Callegan
Progress in Retinal and Eye Research.2019;73(17)100763
[DOI]
6ICAM3 mediates tumor metastasis via a LFA-1-ICAM3-ERM dependent manner
Wenzhi Shen,Xiaoyuan Zhang,Renle Du,Yan Fan,Dehong Luo,Yonghua Bao,Wancai Yang,Na Luo,Yunping Luo,Shuangtao Zhao
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2018;1864(8)2566
[DOI]
7Reconsidering the central role of mucins in dry eye and ocular surface diseases
Christophe Baudouin,Maurizio Rolando,Jose M. Benitez Del Castillo,Elisabeth M. Messmer,Francisco C. Figueiredo,Murat Irkec,Gysbert Van Setten,Marc Labetoulle
Progress in Retinal and Eye Research.2019;71(8)68
[DOI]
8Reconsidering the central role of mucins in dry eye and ocular surface diseases
Caterina Sarnicola,Enrica Sarnicola,Paolo Perri,Vincenzo Sarnicola
Progress in Retinal and Eye Research.2020;71(8)35
[DOI]
9Correlation of clinical symptoms and signs with conjunctival gene expression in primary Sjögren syndrome dry eye patients
H. Liang,K. Kessal,G. Rabut,P. Daull,J.S. Garrigue,S. Melik Parsadaniantz,M. Docquier,C. Baudouin,F. Brignole-Baudouin
The Ocular Surface.2019;17(3)516
[DOI]
10Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease
Abhirup Mandal,Vrinda Gote,Dhananjay Pal,Abayomi Ogundele,Ashim K. Mitra
Pharmaceutical Research.2019;36(2)516
[DOI]
11Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease
Dorota Kopacz,Piotr Maciejewicz
Pharmaceutical Research.2019;36(2)516
[DOI]
12The role of lipids in corneal diseases and dystrophies: a systematic review
Tyler G. Rowsey,Dimitrios Karamichos
Clinical and Translational Medicine.2017;6(1)516
[DOI]
  Feedback 
  Subscribe